Exploratory proteomic analysis of hypobaric hypoxia and acute mountain sickness in humans

Journal of Applied Physiology

Volumn 116, Issue 7, 2014, Pages 937-944

  Julian, Colleen G ^a   Subudhi, Andrew W ^a,b   Hill, Ryan C ^a   Wilson, Megan J ^a   Dimmen, Andrew C ^a   Hansen, Kirk C ^a   Roach, Robert C ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Acute mountain sickness; Hypoxia; Proteomics

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; ENZYME; PLASMA PROTEIN;

ACCLIMATIZATION; ACUTE DISEASE; ADULT; ALTITUDE; ALTITUDE SICKNESS; ANOXIA; BLOOD; CASE CONTROL STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROCEDURES; PROTEOMICS; TANDEM MASS SPECTROMETRY; TIME;

ACCLIMATIZATION; ACUTE DISEASE; ADULT; ALTITUDE; ALTITUDE SICKNESS; ANOXIA; ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYMES; FEMALE; HUMANS; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEOMICS; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 84901194640     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00362.2013     Document Type: Article

References (55)

1. Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 20: 131-147, 2000.
2. Ahmad Y, Sharma NK, Garg I, Ahmad MF, Sharma M, Bhargava K. An insight into the changes in human plasma proteome on adaptation to hypobaric hypoxia. PLos One 8: e67548, 2013.
3. Albitar M, Potts SJ, Giles FJ, O'Brien S, Jilani I, Donahue AC, Estey EH, Kantarjian H. Proteomics-based prediction of clinical response in acute myeloid leukemia. Exp Hematol 37: 784-790, 2009.
4. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1: 845-867, 2002.
5. Bailey DM, Davies B. Acute mountain sickness; prophylactic benefits of antioxidant vitamin supplementation at high altitude. High Alt Med Biol 2: 21-29, 2001.
6. Bailey DM, Evans KA, James PE, McEneny J, Young IS, Fall L, Gutowski M, Kewley E, McCord JM, Moller K, Ainslie PN. Altered free radical metabolism in acute mountain sickness: implications for dynamic cerebral autoregulation and blood-brain barrier function. J Physiol 587: 73-85, 2009.
7. Bailey DM, Roukens R, Knauth M, Kallenberg K, Christ S, Mohr A, Genius J, Storch-Hagenlocher B, Meisel F, McEneny J, Young IS, Steiner T, Hess K, Bartsch P. Free radical-mediated damage to barrier function is not associated with altered brain morphology in high-Altitude headache. J Cereb Blood Flow Metab 26: 99-111, 2006.
8. Bailey DM, Taudorf S, Berg RM, Lundby C, McEneny J, Young IS, Evans KA, James PE, Shore A, Hullin DA, McCord JM, Pedersen BK, Moller K. Increased cerebral output of free radicals during hypoxia: implications for acute mountain sickness? Am J Physiol Regul Integr Comp Physiol 297: R1283-R1292, 2009.
9. Baillie JK, Thompson AA, Irving JB, Bates MG, Sutherland AI, Macnee W, Maxwell SR, Webb DJ. Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial. QJM 102: 341-348, 2009.
10. Bartsch P, Bailey DM, Berger MM, Knauth M, Baumgartner RW. Acute mountain sickness: controversies and advances. High Alt Med Biol 5: 110-124, 2004.
11. Bonello S, Zahringer C, BelAiba RS, Djordjevic T, Hess J, Michiels C, Kietzmann T, Gorlach A. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol 27: 755-761, 2007.
12. Chen JW, Dodia C, Feinstein SI, Jain MK, Fisher AB. 1-Cys perox-iredoxin, a bifunctional enzyme with glutathione peroxidase and phospho-lipase A2 activities. J Biol Chem 275: 28421-28427, 2000.
13. Chowdhury I, Mo Y, Gao L, Kazi A, Fisher AB, Feinstein SI. Oxidant stress stimulates expression of the human peroxiredoxin 6 gene by a transcriptional mechanism involving an antioxidant response element. Free Radic Biol Med 46: 146-153, 2009.
14. Coppock DL, Thorpe C. Multidomain flavin-dependent sulfhydryl oxi-dases. Antioxid Redox Signal 8: 300-311, 2006.
15. Diet A, Abbas K, Bouton C, Guillon B, Tomasello F, Fourquet S, Toledano MB, Drapier JC. Regulation of peroxiredoxins by nitric oxide in immunostimulated macrophages. J Biol Chem 282: 36199-36205, 2007.
16. Diz AP, Truebano M, Skibinski DO. The consequences of sample pooling in proteomics: an empirical study. Electrophoresis 30: 2967-2975, 2009.
17. Fandrey J, Frede S, Jelkmann W. Role of hydrogen peroxide in hypoxia-induced erythropoietin production. Biochem J 303: 507-510, 1994.
18. Fisher AB. Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A(2) activities. Antioxid Redox Signal 15: 831-844, 2011.
19. Fujii J, Ikeda Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep 7: 123-130, 2002.
20. Hackett PH, Roach RC. High-Altitude illness. N Engl J Med 345: 107-114, 2001.
21. Han ES, Wu Y, McCarter R, Nelson JF, Richardson A, Hilsenbeck SG. Reproducibility, sources of variability, pooling, and sample size: important considerations for the design of high-density oligonucleotide array experiments. J Gerontol A Biol Sci Med Sci 59: 306-315, 2004.
22. Hofmann B, Hecht HJ, Flohe L. Peroxiredoxins. Biol Chem 383: 347-364, 2002.
23. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57, 2009.
24. Huang LE, Arany Z, Livingston DM, Bunn HF. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 271: 32253-32259, 1996.
25. Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophys-iology of tight junctions in the blood-brain barrier. Trends Neurosci 24: 719-725, 2001.
26. Julian CG, Subudhi AW, Wilson MJ, Dimmen AC, Pecha T, Roach RC. Acute mountain sickness, inflammation and permeability: new insights from a blood biomarker study. J Appl Physiol 111: 392-399, 2011.
27. Kallenberg K, Dehnert C, Dorfler A, Schellinger PD, Bailey DM, Knauth M, Bartsch PD. Microhemorrhages in nonfatal high-Altitude cerebral edema. J Cereb Blood Flow Metab 28: 1635-1642, 2008.
28. Karp NA, Lilley KS. Investigating sample pooling strategies for DIGE experiments to address biological variability. Proteomics 9: 388-397, 2009.
29. Kendziorski C, Irizarry RA, Chen KS, Haag JD, Gould MN. On the utility of pooling biological samples in microarray experiments. Proc Natl Acad Sci USA 102: 4252-4257, 2005.
30. Kim SY, Chun E, Lee KY. Phospholipase A(2) of peroxiredoxin 6 has a critical role in tumor necrosis factor-induced apoptosis. Cell Death Differ 18: 1573-1583, 2011.
31. Lisk C, McCord J, Bose S, Sullivan T, Loomis Z, Nozik-Grayck E, Schroeder T, Hamilton K, Irwin DC. Nrf2 activation: a potential strategy for the prevention of acute mountain sickness. Free Radic Biol Med 63: 264-273, 2013.
32. Liu H, Sadygov RG, Yates JR 3rd. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 76: 4193-4201, 2004.
33. Mallick P, Kuster B. Proteomics: a pragmatic perspective. Nat Biotech-nol 28: 695-709, 2010.
34. Matsuzawa Y, Kobayashi T, Fujimoto K, Shinozaki S, Yoshikawa S. Cerebral edema in acute mountain sickness. In: High Altitude Medicine, edited by G. Ueda and M. Sekiguchi. Matsumoto, Japan: Shinshu University Press, 1992, pp. 300-304.
35. Meier P, Renga M, Hoppeler H, Baum O. The impact of antioxidant supplements and endurance exercise on genes of the carbohydrate and lipid metabolism in skeletal muscle of mice. Cell Biochem Funct 31: 51-59, 2013.
36. Morel C, Adami P, Musard JF, Duval D, Radom J, Jouvenot M. Involvement of sulfhydryl oxidase QSOX1 in the protection of cells against oxidative stress-induced apoptosis. Exp Cell Res 313: 3971-3982, 2007.
37. Murakoshi Y, Honda K, Sasazuki S, Ono M, Negishi A, Matsubara J, Sakuma T, Kuwabara H, Nakamori S, Sata N, Nagai H, Ioka T, Okusaka T, Kosuge T, Shimahara M, Yasunami Y, Ino Y, Tsuchida A, Aoki T, Tsugane S, Yamada T. Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray. Cancer Sci 102: 630-638.
38. Niecknig H, Tug S, Reyes BD, Kirsch M, Fandrey J, Berchner-Pfannschmidt U. Role of reactive oxygen species in the regulation of HIF-1 by prolyl hydroxylase 2 under mild hypoxia. Free Radic Res 46: 705-717, 2012.
39. O'Brien JH, Vanderlinden LA, Schedin PJ, Hansen KC. Rat mammary extracellular matrix composition and response to ibuprofen treatment during postpartum involution by differential GeLC-MS/MS analysis. J Proteome Res 11: 4894-4905, 2012.
40. Okano T, Kondo T, Fujii K, Nishimura T, Takano T, Ohe Y, Tsuta K, Matsuno Y, Gemma A, Kato H, Kudoh S, Hirohashi S. Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adeno-carcinoma. Clin Cancer Res 13: 799-805, 2007.
41. Peng X, Wood CL, Blalock EM, Chen KC, Landfield PW, Stromberg AJ. Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics 4: 26, 2003.
42. Radom J, Colin D, Thiebault F, Dognin-Bergeret M, Mairet-Coello G, Esnard-Feve A, Fellmann D, Jouvenot M. Identification and expression of a new splicing variant of FAD-sulfhydryl oxidase in adult rat brain. Biochim Biophys Acta 1759: 225-233, 2006.
43. Rink C, Khanna S. Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke. Antioxid Redox Signal 14: 1889-1903, 2011.
44. Roach RCBP, Hackett P, Oelz O. The Lake Louise acute mountain sickness scoring system. In: Hypoxia and Molecular Medicine. Burlington, VT: Queen City Printers, 1993, p. 272-274.
45. Roach RC, Hackett PH. Frontiers of hypoxia research: acute mountain sickness. J Exp Biol 204: 3161-3170, 2001.
46. Roach RC, Maes D, Sandoval D, Robergs RA, Icenogle M, Hinghofer-Szalkay H, Lium D, Loeppky JA. Exercise exacerbates acute mountain sickness at simulated high altitude. J Appl Physiol 88: 581-585, 2000.
47. Schoonman GG, Sandor PS, Nirkko AC, Lange T, Jaermann T, Dydak U, Kremer C, Ferrari MD, Boesiger P, Baumgartner RW. Hypoxia-induced acute mountain sickness is associated with intracellular cerebral edema: a 3 T magnetic resonance imaging study. J Cereb Blood Flow Metab 28: 198-206, 2008.
48. Sinha S, Ray US, Tomar OS, Singh SN. Different adaptation patterns of antioxidant system in natives and sojourners at high altitude. Respir Physiol Neurobiol 167: 255-260, 2009.
49. Speers AE, Blackler AR, Wu CC. Shotgun analysis of integral membrane proteins facilitated by elevated temperature. Anal Chem 79: 4613-4620, 2007.
50. Stamatovic SM, Dimitrijevic OB, Keep RF, Andjelkovic AV. Inflammation and brain edema: new insights into the role of chemokines and their receptors. Acta Neurochir Suppl (Wien) 96: 444-450, 2006.
51. Subudhi AW, Dimmen AC, Julian CG, Wilson MJ, Panerai RB, Roach RC. Effects of acetazolamide and dexamethasone on cerebral hemodynamics in hypoxia. J Appl Physiol 110: 1219-1225, 2011.
52. Subudhi AW, Panerai RB, Roach RC. Effects of hypobaric hypoxia on cerebral autoregulation. Stroke 41: 641-646.
53. Wilson MH, Milledge J. Direct measurement of intracranial pressure at high altitude and correlation of ventricular size with acute mountain sickness: Brian Cummins' results from the 1985 Kishtwar expedition. Neurosurgery 63: 970-975, 2008.
54. Wood ZA, Schroder E, Robin Harris J, Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28: 32-40, 2003.
55. Zolotarjova N, Mrozinski P, Chen H, Martosella J. Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum. J Chromatogr A 1189: 332-338, 2008.